In her first full year at the top of cystic fibrosis juggernaut Vertex Pharmaceuticals, CEO Reshma Kewalramani has collected a pay package that rivals compensation at some Big Pharma companies.
With Merck taking the reins from retiring CEO Ken Frazier and handing them to Robert Davis at the exact midway point of 2021, how would the New Jersey-based drugmaker divvy up their pay for the yea